-
psnet.ahrq.gov/node/866579/psn-pdf
August 28, 2024 - 40), diabetes, inflammatory arthritis, peripheral vascular disease, chronic liver
disease, chronic lung
-
effectivehealthcare.ahrq.gov/health-topics/pneumonia
-
effectivehealthcare.ahrq.gov/health-topics/chronic-bronchitis
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_A.PDF
January 01, 2004 - , August 31, 2006
APRDRG Frequency
Percent
of
Total
1: LIVER TRANSPLANT 142 0.02
2: HEART &/OR LUNG … 2.76
140: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13219 1.65
141: ASTHMA 6047 0.76
142: INTERSTITIAL LUNG … CHOLECYSTECT W/O CDE W CC 2246 0.28
4932: LAPAROSCOPIC CHOLECYSTECT W/O CDE W MCC 350 0.04
4950: LUNG … TRANSPLANT W/O CC <= 10 **.**
4951: LUNG TRANSPLANT W CC <= 10 **.**
4952: LUNG TRANSPLANT W MCC 12 … RES11: Influenza 424 0.05
RES12: Mycoplasma pneumoniae Infection 104 0.01
RES13: Neoplasm, Malignant: Lungs
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2004 - , August 31, 2006
APRDRG Frequency
Percent
of
Total
1: LIVER TRANSPLANT 137 0.02
2: HEART &/OR LUNG … 2.75
140: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13243 1.65
141: ASTHMA 6110 0.76
142: INTERSTITIAL LUNG … CHOLECYSTECT W/O CDE W CC 2229 0.28
4932: LAPAROSCOPIC CHOLECYSTECT W/O CDE W MCC 353 0.04
4950: LUNG … TRANSPLANT W/O CC <= 10 **.**
4951: LUNG TRANSPLANT W CC <= 10 **.**
4952: LUNG TRANSPLANT W MCC < … RES11: Influenza 437 0.05
RES12: Mycoplasma pneumoniae Infection 121 0.02
RES13: Neoplasm, Malignant: Lungs
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SEVERITY_A.PDF
January 01, 2002 - .: Missing 35974 4.58
1: LIVER TRANSPLANT 102 0.01
2: HEART &/OR LUNG TRANSPLANT 67 0.01
3: BONE MARROW … 2.75
140: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13026 1.66
141: ASTHMA 6220 0.79
142: INTERSTITIAL LUNG … CHOLECYSTECT W/O CDE W CC 2114 0.27
4932: LAPAROSCOPIC CHOLECYSTECT W/O CDE W MCC 311 0.04
4950: LUNG … TRANSPLANT W/O CC <= 10 **.**
4951: LUNG TRANSPLANT W CC <= 10 **.**
4952: LUNG TRANSPLANT W MCC < … RES11: Influenza 449 0.06
RES12: Mycoplasma pneumoniae Infection 96 0.01
RES13: Neoplasm, Malignant: Lungs
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2003_SummaryStats_SEVERITY.PDF
January 01, 2003 - December 14, 2005
APRDRG Frequency
Percent
of
Total
1: LIVER TRANSPLANT 335 0.01
2: HEART &/OR LUNG … 3.14
140: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 839 0.03
141: ASTHMA 100665 3.37
142: INTERSTITIAL LUNG … CHOLECYSTECT W/O CDE W CC 1906 0.06
4932: LAPAROSCOPIC CHOLECYSTECT W/O CDE W MCC 132 0.00
4950: LUNG … TRANSPLANT W/O CC <= 10 **.**
4951: LUNG TRANSPLANT W CC <= 10 **.**
4952: LUNG TRANSPLANT W MCC 34 … Influenza 16207 0.54
RES12: Mycoplasma pneumoniae Infection 1876 0.06
RES13: Neoplasm, Malignant: Lungs
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2002 - .: Missing 35975 4.58
1: LIVER TRANSPLANT 101 0.01
2: HEART &/OR LUNG TRANSPLANT 60 0.01
3: BONE MARROW … 2.78
140: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12735 1.62
141: ASTHMA 5929 0.75
142: INTERSTITIAL LUNG … CHOLECYSTECT W/O CDE W CC 2118 0.27
4932: LAPAROSCOPIC CHOLECYSTECT W/O CDE W MCC 305 0.04
4950: LUNG … TRANSPLANT W/O CC <= 10 **.**
4951: LUNG TRANSPLANT W CC 11 0.00
4952: LUNG TRANSPLANT W MCC 13 0.00 … : Influenza 446 0.06
RES12: Mycoplasma pneumoniae Infection 109 0.01
RES13: Neoplasm, Malignant: Lungs
-
effectivehealthcare.ahrq.gov/health-topics/bronchial-disorders
-
www.ahrq.gov/sites/default/files/2024-05/gore-report.pdf
January 01, 2024 - Jennifer Temel, which
found that providing palliative care to patients with lung cancer improved the … Cost analysis of a randomized trial of early palliative care in
patients with metastatic nonsmall-cell lung … JS, Greer JA, Muzikansky A et al: Early palliative care for patients with metastatic non–small-cell lung
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V22%20Definitions%20Manual.pdf
April 01, 2006 - Heart Assist System
480 Liver Transplant &/or Intestinal Transplant
481 Bone Marrow Transplant
495 Lung … Heart Assist System
480 Liver Transplant &/or Intestinal Transplant
481 Bone Marrow Transplant
495 Lung … CHEMO
493 493 LAPAROSCOPIC CHOLECYSTECT W/O CDE
494 493 LAPAROSCOPIC CHOLECYSTECT W/O CDE
495 495 LUNG
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_SEVERITY.PDF
January 01, 2002 - .: Missing 359747 4.58
1: LIVER TRANSPLANT 958 0.01
2: HEART &/OR LUNG TRANSPLANT 579 0.01
3: BONE … 140: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 129958 1.65
141: ASTHMA 61461 0.78
142: INTERSTITIAL LUNG … CHOLECYSTECT W/O CDE W CC 21205 0.27
4932: LAPAROSCOPIC CHOLECYSTECT W/O CDE W MCC 3102 0.04
4950: LUNG … TRANSPLANT W/O CC 36 0.00
4951: LUNG TRANSPLANT W CC 81 0.00
4952: LUNG TRANSPLANT W MCC 90 0.00 … Influenza 4478 0.06
RES12: Mycoplasma pneumoniae Infection 1036 0.01
RES13: Neoplasm, Malignant: Lungs
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2003 - .: Missing 41678 5.22
1: LIVER TRANSPLANT 84 0.01
2: HEART &/OR LUNG TRANSPLANT 58 0.01
3: BONE MARROW … 2.86
140: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13661 1.71
141: ASTHMA 6801 0.85
142: INTERSTITIAL LUNG … CHOLECYSTECT W/O CDE W CC 2171 0.27
4932: LAPAROSCOPIC CHOLECYSTECT W/O CDE W MCC 331 0.04
4950: LUNG … TRANSPLANT W/O CC <= 10 **.**
4951: LUNG TRANSPLANT W CC <= 10 **.**
4952: LUNG TRANSPLANT W MCC 16 … Influenza 1101 0.14
RES12: Mycoplasma pneumoniae Infection 116 0.01
RES13: Neoplasm, Malignant: Lungs
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/rt-bone-metatases-final-protocol-amendment.pdf
August 10, 2022 - seen from solid primary tumors originating from the prostate (89%), breast
(54%), kidneys (39%) and lung … Natural history of skeletal-related events in
patients with breast, lung, or prostate cancer and metastases
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_disposition-comments.pdf
September 23, 2014 - To perform an operation without assessment of
liver or lung metastases is malpractice. … It can be used for
lung cancer where a nodule is easy to detect
against a background of air.
-
hcup-us.ahrq.gov/reports/trendtables/HCUPSummaryTrendTables_Methods.xlsx
December 01, 2022 - include other Federal and local government programs (e.g., TRICARE, CHAMPVA, Indian Health Service, Black Lung … include other Federal and local government programs (e.g., TRICARE, CHAMPVA, Indian Health Service, Black Lung
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - Tyrosine kinase
associated with
EGFR
Treatment of locally advanced or metastatic non–
small cell lung … treatment of breast cancer,
epidermoidcarcinomas of the head and neck, advanced mycosis fungoides, lung
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
July 01, 2012 - Alternatively, those with obstructive lung disease tend to have more end
expiratory pressure resistance … Role of noninvasive ventilation in
acute lung injury/acute respiratory distress syndrome: a proportion
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
November 21, 2019 - or IV), advanced chronic obstructive pulmonary
disease (Global Initiative for Chronic Obstructive Lung … training and educational materials;
Patient/caregiver educational
materials/resources
American Lung
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-research-report-integrating-health-system-data.pdf
April 01, 2020 - Is
symptom-based diagnosis of lung cancer
possible? … A systematic review and meta-
analysis of symptomatic lung cancer prior to
diagnosis for comparison